Research & Investigations

Our mission is not only to treat illness, but to relentlessly search for better ways to unlock the mysteries of disease.

Today, with support from the University of Rochester Medical Center, the Cancer Center has extraordinary opportunities to better understand cancers and develop breakthrough approaches to diagnosis and therapy through research. With growing programs in lung biology, immunology, genetics, cell biology, and DNA repair, we’re bolstering both basic and translational research— leading to innovations that quickly bring discoveries from the bench to the bedside.

The most profound impact is being felt by those who seek care. Breakthrough treatments are available faster in Rochester because of this research enterprise. Some of the nation’s best medical minds are present in our community, working together to translate new scientific knowledge into tomorrow’s health care, care that prevents, arrests or repairs the ravages of disease.

Switching on the Fly Genome Dirk Bohmann and Henri Jasper examine a fruitfly embryo under the microscope. The researchers have now moved the group to the Department of Biomedical Genetics at the University of Rochester, New York. Photo: Hartmut Land

Stem Cell Researcher Joins the James P. Wilmot Cancer Center

Craig Jordan, Ph.D.

Craig T. Jordan, Ph.D., a leader in leukemia and stem cell research, was named director of the hematologic malignancies translational research program at the James P. Wilmot Cancer Center. He is an associate professor of medicine in the Hematology-Oncology Unit and associate professor in the Center for Human Genetics and Molecular Pediatric Diseases, Aab Institute.

Read more about Craig Jordan

Scroll to Top